Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Parke-Davis identifies potent inhibitor of PDGF receptor TK and PDGF-dependent tumor growth

Nov. 20, 1998

Antitumor tetramic acid compound produced by Streptomyces

Nov. 20, 1998

Clarion prepares novel compounds for cancer, psoriasis and inflammation

Nov. 20, 1998

Vertex reports preliminary data on Incel in soft tissue carcinoma and initiates new phase II trial

Nov. 20, 1998

MPIF advances to phase II trials in cancer patients

Nov. 19, 1998

First potent, orally active LHRH antagonist discovered by Takeda

Nov. 19, 1998

U.S. patent protects methods of angiogenesis inhibition using Xoma's BPI products

Nov. 19, 1998

FDA advisory committee issues positive statement on DepoCyt

Nov. 18, 1998

Novel MMP inhibitor synthesized at Abbott shows potent antitumor activity in vivo

Nov. 18, 1998

Nolvadex now available for breast cancer prevention

Nov. 17, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...